2022 Annual Meeting | C157 - Clinical EMG 1: Principles and Practice of NCS and Needle EMG

Date Thursday 04/07/22

Time 01:00 PM - 03:00 PM PDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program will be available in the meeting's On Demand product.

Event Type Seminar

Director(s) Devon I. Rubin, MD, FAAN

Topic(s) Neuromuscular and Clinical Neurophysiology (EMG)

Learning Objectives Participants should understand the utility of nerve conduction studies (NCS) in the evaluation of neuromuscular diseases; recognize the different patterns of NCS findings and how they correlate with various neuromuscular pathologies; recognize and improve technical issues that may impact the interpretation of NCS; learn the skills necessary to recognize different needle EMG waveforms; and recognize the significant and interpretation of various spontaneous and voluntary EMG waveforms. This program complements Clinical EMG 2: Case-based Clinical Applications of Nerve Conduction Studies and Needle Electromyography but covers independent topics.

CME Available 2.00 CME credits

Core Competencies Patient Care & Procedural Skills, Medical Knowledge

Program Level Intermediate

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Audience Participation

Program Materials Program Evaluations

Event Timeline
01:00 PM - 01:50 PM PDT	Speaker	Nerve Conduction Studies – Utility, Pitfalls, and Practical Findings Ruple S. Laughlin, MD, FAAN
01:00 PM - 01:00 PM PDT	Speaker	Walk-in Slides Devon I. Rubin, MD, FAAN
01:50 PM - 02:40 PM PDT	Speaker	Needle EMG Findings in Neuromuscular Diseases Devon I. Rubin, MD, FAAN
02:40 PM - 03:00 PM PDT	Discussion	Discussion & Questions and Answers

Faculty Disclosures
Devon I. Rubin, MD, FAAN	Dr. Rubin has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for Journal of Clinical Neurophysiology. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received intellectual property interests from a discovery or technology relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care. Dr. Rubin has received publishing royalties from a publication relating to health care.
Ruple S. Laughlin, MD, FAAN	Dr. Laughlin has nothing to disclose.